Register here.

ASH 2018: Dr. Neil Kay on How Stromal Cells Keep CLL (chronic Lymphocytic Leukemia) Cells Alive in the Bone Marrow and How We Can Intervene
So Tired
May 15, 2019: FDA Approved Venetoclax in Combination with Obinutuzumab for the Treatment of People with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Lymphoma (SLL)
Acalabrutinib Phase III ASCEND Trial Met Primary Endpoint at Interim Analysis in Relapsed Or Refractory Chronic Lymphocytic Leukemia and Will Stop Early